Herantis Pharma Oyj Herantis Pharma Oyj

Herantis Pharma Oyj

HRTIS

Rank in Stocks #23483
Herantis Pharma Oyj, a biotechnology company founded in Espoo, Finland, in... Herantis Pharma Oyj, a biotechnology company founded in Espoo, Finland, in 2008, is dedicated to developing innovative, disease-modifying CDNF-based treatments for Parkinson's disease (PD). Its pipeline features two key assets: HER-096, an advanced small, synthetic chemical peptidomimetic (a modified version of the active CDNF parent molecule) which is in preclinical stages as an xCDNF candidate for Parkinson's and other neurodegenerative conditions; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein currently in Phase I clinical trials for patients with PD.
Share Price
$1.54
Last synced: 2026-11-18
Market Cap
$39.79M
Change (1 day)
3.57%
Change (1 year)
-37.37%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Herantis Pharma Oyj (HRTIS)
Operating Margin as of November 2026 TTM: 0.00%
According to Herantis Pharma Oyj's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Herantis Pharma Oyj from 2011 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% -100.00%
2016 -17,477.28% -97.89%
2015 -826,905.37% -13.61%
2014 -957,125.00% 0.00%
2013 0.00% -100.00%
2012 -965,677.45% 0.00%
2011 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Herantis Pharma Oyj's operating margin

What was Herantis Pharma Oyj's operating margin in 2025?

In 2025, Herantis Pharma Oyj's operating margin was 0.00%, compared with 0.00% in 2024.

How has Herantis Pharma Oyj's operating margin changed since 2020?

From 2020 to 2025, Herantis Pharma Oyj's operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).

How does Herantis Pharma Oyj's operating margin compare with similar companies?

Herantis Pharma Oyj's operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.